James A. Rogers

3.9k total citations · 1 hit paper
106 papers, 2.9k citations indexed

About

James A. Rogers is a scholar working on Molecular Biology, Pharmaceutical Science and Organic Chemistry. According to data from OpenAlex, James A. Rogers has authored 106 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 18 papers in Pharmaceutical Science and 13 papers in Organic Chemistry. Recurrent topics in James A. Rogers's work include Lipid Membrane Structure and Behavior (19 papers), Drug Solubulity and Delivery Systems (12 papers) and Surfactants and Colloidal Systems (9 papers). James A. Rogers is often cited by papers focused on Lipid Membrane Structure and Behavior (19 papers), Drug Solubulity and Delivery Systems (12 papers) and Surfactants and Colloidal Systems (9 papers). James A. Rogers collaborates with scholars based in Canada, United States and Iran. James A. Rogers's co-authors include V. Wee Yong, Luanne M. Metz, G. V. Betageri, Keith E. Anderson, Chun‐Hua Dong, Young Wook Choi, Masood N. Khan, Jean W. Lee, Russell Weiner and Stephen Keller and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

James A. Rogers

97 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fit-for-Purpose Method Development and Validation for Successful Biomarker Measurement

2006 504 citations James A. Rogers et al. Pharmaceutical Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James A. Rogers Canada	28	1.0k	508	382	281	271	106	2.9k
Frank Sinner Austria	32	1.2k 1.2×	329 0.6×	315 0.8×	43 0.2×	338 1.2×	91	3.4k
Leonard M. Hjelmeland United States	36	3.4k 3.4×	278 0.5×	69 0.2×	148 0.5×	273 1.0×	97	5.5k
Yue Zhao China	38	2.8k 2.7×	354 0.7×	232 0.6×	98 0.3×	62 0.2×	154	4.5k
Yoshihiko Watanabe Japan	33	862 0.9×	380 0.7×	94 0.2×	102 0.4×	286 1.1×	231	3.9k
Yoram Shechter Israel	43	3.6k 3.6×	554 1.1×	84 0.2×	119 0.4×	155 0.6×	124	7.0k
Michele Maffia Italy	32	1.6k 1.6×	346 0.7×	52 0.1×	132 0.5×	94 0.3×	140	3.6k
Péter Buchwald United States	35	1.3k 1.3×	203 0.4×	296 0.8×	32 0.1×	248 0.9×	151	3.8k
Yinglan Zhao China	40	2.9k 2.9×	369 0.7×	96 0.3×	101 0.4×	126 0.5×	160	5.4k
Ismail Kola Australia	43	4.0k 4.0×	921 1.8×	75 0.2×	140 0.5×	164 0.6×	94	8.1k
Hans Ehrsson Sweden	36	1.1k 1.1×	99 0.2×	110 0.3×	61 0.2×	411 1.5×	121	3.6k

Countries citing papers authored by James A. Rogers

Since Specialization

Citations

This map shows the geographic impact of James A. Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James A. Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James A. Rogers more than expected).

Fields of papers citing papers by James A. Rogers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James A. Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James A. Rogers. The network helps show where James A. Rogers may publish in the future.

Co-authorship network of co-authors of James A. Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of James A. Rogers. A scholar is included among the top collaborators of James A. Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James A. Rogers. James A. Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rogers, James A., et al.. (2024). Bayesian sparse regression for exposure–response analyses of efficacy and safety endpoints to justify the clinical dose of valemetostat for adult T‐cell leukemia/lymphoma. CPT Pharmacometrics & Systems Pharmacology. 13(10). 1655–1669. 5 indexed citations

Sanghavi, Kinjal, Jakob Ribbing, James A. Rogers, et al.. (2024). Covariate modeling in pharmacometrics: General points for consideration. CPT Pharmacometrics & Systems Pharmacology. 13(5). 710–728. 22 indexed citations

Neubacher, Dietmar, et al.. (2024). Pharmacometrics-Enhanced Bayesian Borrowing for Pediatric Extrapolation – A Case Study of the DINAMO Trial. Therapeutic Innovation & Regulatory Science. 59(1). 112–123. 1 indexed citations

French, Jonathan, et al.. (2023). Confounded exposure metrics. CPT Pharmacometrics & Systems Pharmacology. 13(2). 187–191. 11 indexed citations

Hamilton, Alastair, Nils D. Forkert, Runze Yang, et al.. (2019). Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis. Scientific Reports. 9(1). 8488–8488. 36 indexed citations

Nathoo, Nabeela, James A. Rogers, V. Wee Yong, & Jeff F. Dunn. (2015). Detecting Deoxyhemoglobin in Spinal Cord Vasculature of the Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis Using Susceptibility MRI and Hyperoxygenation. PLoS ONE. 10(5). e0127033–e0127033. 8 indexed citations

Gross, Jorge Luiz, James A. Rogers, William R. Gillespie, et al.. (2013). A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications: an example using DPP-4 inhibitors, sitagliptin and linagliptin, in treatment of type 2 diabetes mellitus. BMJ Open. 3(3). e001844–e001844. 29 indexed citations

Han, Mei, James A. Rogers, Bhavna Lavingia, & Peter Šťastný. (2008). Peripheral blood B cells producing donor-specific HLA antibodies in vitro. Human Immunology. 70(1). 29–34. 49 indexed citations

Montaseri, Hashem, et al.. (2005). THE EFFECT OF TEMPERATURE, PH, AND DIFFERENT SOLUBILIZING AGENTS ON STABILITY OF TAXOL. Iranian journal of pharmaceutical sciences. 1(1). 43–51. 8 indexed citations

10.

Lin, Shili, James A. Rogers, & Jason C. Hsu. (2001). A Confidence-Set Approach for Finding Tightly Linked Genomic Regions. The American Journal of Human Genetics. 68(5). 1219–1228. 11 indexed citations

11.

Anderson, Keith E., Bruce R. Stevenson, & James A. Rogers. (1999). Folic acid–PEO-labeled liposomes to improve gastrointestinal absorption of encapsulated agents. Journal of Controlled Release. 60(2-3). 189–198. 40 indexed citations

12.

Ghahary, Aziz, et al.. (1997). Liposome-Associated Interferon-α-2b Functions as an Anti-Fibrogenic Factor for Human Dermal Fibroblasts. Journal of Investigative Dermatology. 109(1). 55–60. 18 indexed citations

13.

Rogers, James A., et al.. (1996). Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres. Journal of Microencapsulation. 13(2). 195–205. 11 indexed citations

14.

Rogers, James A., et al.. (1995). Polymer-coated liposomes: Improved liposome stability and release of cytosine arabinoside (Ara-C). Journal of Microencapsulation. 12(1). 37–47. 30 indexed citations

15.

Rogers, James A. & Young Wook Choi. (1993). The Liposome Partitioning System for Correlating Biological Activities of Imidazolidine Derivatives. Pharmaceutical Research. 10(6). 913–917. 52 indexed citations

16.

Rogers, James A., et al.. (1993). Acacia-Gelatin Microencapsulated Liposomes: Preparation, Stability, and Release of Acetylsalicylic Acid. Pharmaceutical Research. 10(1). 141–146. 20 indexed citations

17.

Rogers, James A., et al.. (1992). Microencapsulation of Solid Dispersions: Release of Griseofulvin from Griseofulvin:Phospholipid Coprecipitates in Microspheres. Pharmaceutical Research. 9(6). 759–763. 7 indexed citations

18.

Betageri, G. V., Yves Thériault, & James A. Rogers. (1989). NMR Study of the Interaction of Beta-Blockers with Sonicated Dimyristoylphosphatidylcholine Liposomes in the Presence of Praseodymium Cation. PubMed. 8(4). 197–206. 11 indexed citations

19.

Venkataram, S. & James A. Rogers. (1988). Characteristics of Drug-Phospholipid Coprecipitates II: Bioavailability Studies of Griseofulvin in Rats. Journal of Pharmaceutical Sciences. 77(11). 933–936. 12 indexed citations

20.

Rogers, James A., et al.. (1985). Simultaneous Spectrofluorometric Determination of Aspirin and Salicylic Acid in Aqueous Solution. Pharmaceutical Research. 2(3). 148–149. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact